Not applicableStudy completedNCT02490007What this trial is testingPertussis Immunisation and Food AllergyWho this might be right forFood Allergy Telethon Kids Institute 508
Large-scale testing (Phase 3)Study completedNCT00317187What this trial is testingSafety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.Who this might be right forHepatitis BDiphtheriaWhole Cell Pertussis+2 more GlaxoSmithKline 500
Post-approval studies (Phase 4)Study completedNCT00304265What this trial is testingPost-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineWho this might be right forPertussisDiphtheriaTetanus+1 more Sanofi Pasteur, a Sanofi Company 215
Large-scale testing (Phase 3)Study completedNCT00136604What this trial is testingResponse to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30mWho this might be right forWhole Cell PertussisHaemophilus Influenzae Type bHepatitis B+3 more GlaxoSmithKline 617
Large-scale testing (Phase 3)Study completedNCT00317135What this trial is testingSafety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.Who this might be right forDiphtheriaHepatitis BWhole Cell Pertussis+2 more GlaxoSmithKline 500
Post-approval studies (Phase 4)Study completedNCT01491087What this trial is testingSafety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaWho this might be right forDiphtheriaTetanusPertussis+1 more Sanofi Pasteur, a Sanofi Company 900
Large-scale testing (Phase 3)Study completedNCT00169442What this trial is testingImmune Memory of DTPw-HBV/Hib Vaccine Following Primary Vaccination, Immuno & Reacto of a Booster Dose Given in InfantsWho this might be right forWhole Cell PertussisDiphtheriaHepatitis B+2 more GlaxoSmithKline 745
Large-scale testing (Phase 3)Study completedNCT00290303What this trial is testingAssess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy InfantsWho this might be right forHaemophilus Influenzae Type bDiphtheriaWhole Cell Pertussis+2 more GlaxoSmithKline 996
Testing effectiveness (Phase 2)Study completedNCT00317174What this trial is testingAssess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.Who this might be right forHaemophilus Influenzae Type bTetanusWhole Cell Pertussis+2 more GlaxoSmithKline 450
Large-scale testing (Phase 3)Study completedNCT00197275What this trial is testingLot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsWho this might be right forTetanusHepatitis BHaemophilus Influenzae Type b+2 more GlaxoSmithKline 800
Large-scale testing (Phase 3)Study completedNCT00473668What this trial is testingNon-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/HibWho this might be right forWhole Cell PertussisHaemophilus Influenzae Type bTetanus+2 more GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT00317161What this trial is testingImmunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.Who this might be right forDiphtheriaHepatitis BHaemophilus Influenzae Type b+2 more GlaxoSmithKline 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06947499What this trial is testingA Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesWho this might be right forDiphtheriaTetanusPertussis+3 more LG Chem 1,186
Large-scale testing (Phase 3)Study completedNCT00228917What this trial is testingSafety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in ChildrenWho this might be right forWhole Cell PertussisTetanusHepatitis B+3 more GlaxoSmithKline 798
Large-scale testing (Phase 3)Ended earlyNCT00316680What this trial is testingImmuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.Who this might be right forHaemophilus Influenzae Type bDiphtheriaTetanus+2 more GlaxoSmithKline 288
Post-approval studies (Phase 4)UnknownNCT03606096What this trial is testingGambia Pertussis Study (GaPs)Who this might be right forPertussis London School of Hygiene and Tropical Medicine 600
Testing effectiveness (Phase 2)Study completedNCT03566940What this trial is testingAssess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization ScheduleWho this might be right forHealthy Janssen Vaccines & Prevention B.V. 302
Large-scale testing (Phase 3)WithdrawnNCT01003431What this trial is testingThe Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)Who this might be right forRotavirus GastroenteritisDiphtheriaTetanus+1 more Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT01106092What this trial is testingStudy to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy ToddlersWho this might be right forHaemophilus Influenzae Type bTetanusHepatitis B+3 more GlaxoSmithKline 312
Large-scale testing (Phase 3)Study completedNCT00004800What this trial is testingPhase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis VaccinesWho this might be right forPertussis National Institute of Allergy and Infectious Diseases (NIAID) 13,250